These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 8629268

  • 1. [Chronic myeloid leukemia].
    Hehlmann R.
    Ther Umsch; 1996 Feb; 53(2):82-7. PubMed ID: 8629268
    [Abstract] [Full Text] [Related]

  • 2. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K, Minami S, Ueda T, Nishimura M, Tsubaki K, Takemoto Y, Takeshita A, Sao H, Kageyama S, Ueda R, Ohno R.
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [Abstract] [Full Text] [Related]

  • 3. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E, Bandini G, Bonini A, Santucci MA, Martinelli G, Rosti G, Testoni N, Zaccaria A, Tura S.
    Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
    [Abstract] [Full Text] [Related]

  • 4. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Mar; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases].
    Nese M, de Bellis R, Urtiarte R, Di Landro J.
    Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047
    [Abstract] [Full Text] [Related]

  • 6. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F.
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [Abstract] [Full Text] [Related]

  • 7. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.
    Hehlmann R, Berger U, Pfirrmann M, Hochhaus A, Metzgeroth G, Maywald O, Hasford J, Reiter A, Hossfeld DK, Kolb HJ, Löffler H, Pralle H, Queisser W, Griesshammer M, Nerl C, Kuse R, Tobler A, Eimermacher H, Tichelli A, Aul C, Wilhelm M, Fischer JT, Perker M, Scheid C, Schenk M, Weiss J, Meier CR, Kremers S, Labedzki L, Schmeiser T, Lohrmann HP, Heimpel H, German CML-Study Group.
    Leukemia; 2003 Aug; 17(8):1529-37. PubMed ID: 12886239
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Kantarjian HM, Talpaz M.
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099
    [Abstract] [Full Text] [Related]

  • 9. [Interferon alpha--the drug of choice for patients with chronic myeloid leukemia].
    Klamová H, Vítek A, Michalová K, Brezinová J, Moravcová J, Jelínek J, Cermák J.
    Cas Lek Cesk; 1998 Sep 21; 137(18):552-6. PubMed ID: 9818464
    [Abstract] [Full Text] [Related]

  • 10. [Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients].
    Creutzig U, Ritter J, Zimmermann M, Klingebiel T.
    Klin Padiatr; 1996 Sep 21; 208(4):236-41. PubMed ID: 8926689
    [Abstract] [Full Text] [Related]

  • 11. Interferon alpha in the treatment of chronic myelogenous leukemia.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1998 Sep 21; 46(6):347-53. PubMed ID: 9883313
    [Abstract] [Full Text] [Related]

  • 12. Treatment of chronic myelogenous leukemia.
    Giralt S, Kantarjian H, Talpaz M.
    Semin Oncol; 1995 Aug 21; 22(4):396-404. PubMed ID: 7638636
    [Abstract] [Full Text] [Related]

  • 13. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON).
    Muñoz A, Bureo E, Ortega JJ, Richard C, Olivé T, Maldonado MS, Madero L, Díaz MA.
    Haematologica; 1998 Nov 21; 83(11):981-4. PubMed ID: 9864916
    [Abstract] [Full Text] [Related]

  • 14. Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Tomás JF, López-Lorenzo JL, Requena MJ, Aguilar R, Steegmann JL, Cámara R, Alegre A, Arranz R, Figuera A, Fernández-Rañada JM.
    Bone Marrow Transplant; 1998 Jul 21; 22(1):47-51. PubMed ID: 9678795
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.
    Kantarjian H, O'Brien S, Cortes J, Shan J, Giles F, Garcia-Manero G, Verstovsek S, Faderl S, Rios MB, Talpaz M.
    Cancer; 2003 Oct 01; 98(7):1430-7. PubMed ID: 14508830
    [Abstract] [Full Text] [Related]

  • 16. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
    Arana-Trejo RM, Ovilla-Martínez R, Gómez-Morales E, Meillon-García L, Cervantes-Peredo A, González-Llaven J, Pizzuto-Chávez J, Kofman-Alfaro S.
    Rev Invest Clin; 1997 Oct 01; 49(3):209-14. PubMed ID: 9380976
    [Abstract] [Full Text] [Related]

  • 17. [Recent progress in therapy for chronic myelogenous leukemia].
    Urabe A.
    Gan To Kagaku Ryoho; 1997 Jul 01; 24(9):1066-73. PubMed ID: 9239158
    [Abstract] [Full Text] [Related]

  • 18. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
    Kantarjian HM, Talpaz M, O'Brien S, Smith TL, Giles FJ, Faderl S, Thomas DA, Garcia-Manero G, Issa JP, Andreeff M, Kornblau SM, Koller C, Beran M, Keating M, Rios MB, Shan J, Resta D, Capdeville R, Hayes K, Albitar M, Freireich EJ, Cortes JE.
    Clin Cancer Res; 2002 Jul 01; 8(7):2177-87. PubMed ID: 12114418
    [Abstract] [Full Text] [Related]

  • 19. Effects of age on prognosis with imatinib mesylate therapy for patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
    Cortes J, Talpaz M, O'Brien S, Giles F, Beth Rios M, Shan J, Faderl S, Garcia-Manero G, Ferrajoli A, Wierda W, Kantarjian H.
    Cancer; 2003 Sep 15; 98(6):1105-13. PubMed ID: 12973833
    [Abstract] [Full Text] [Related]

  • 20. [Interferon-alpha in chronic myeloid leukemia].
    Hehlmann R.
    Fortschr Med; 1997 Mar 30; 115(9):30-4, 37-8. PubMed ID: 9206694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.